Phase II Clinical Trial of Interleukin-2 in AD

Clinical trial NCT06096090 · UNKNOWN

Trial details

NCT number: NCT06096090
Sponsor: The Methodist Hospital Research Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2022-01-01
Primary completion: 2025-12-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.